Dr. Jie Sun 孙洁
Chief Physician, Associate Professor
Bone Marrow Transplantation Center, Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and treatment of acute and chronic leukemia, myelodysplastic syndromes, bone marrow fibrosis, lymphoma, and myeloma. Specializes in elderly leukemia, micro-transplantation, and molecular targeted therapy for malignant blood diseases.
Dr. Sun holds a medical degree from Zhejiang Medical University (1996) and a PhD from Zhejiang University School of Medicine (2004). Completed a two-year fellowship at the Ottawa Hospital in Canada. With over 20 years of clinical experience, Dr. Sun serves as a doctoral supervisor and associate professor. Research focuses on elderly leukemia, cellular immunotherapy, and molecular mechanisms of malignant blood diseases.
Professional roles
- Standing Committee Member, Leukemia Branch, China Medical Education Association
- Standing Committee Member, Integrated Traditional Chinese and Western Medicine Leukemia Professional Committee, China Anti-Cancer Association
- Standing Committee Member, Hematopoietic Stem Cell Transplantation and Cell Therapy Professional Committee, China Medical Association
- Member, Leukemia Group, Hematology Branch, Chinese Medical Doctor Association
Name order: in Chinese the family name comes first (Sun Jie). Papers usually list the name as Jie Sun or Sun J.
Selected publications
96 papers on PubMed matched by name and affiliation; 28 as first or senior author since 2016. Most recent first- or senior-author papers:
- Cell Rep, 2026 (senior author): Calibration of CAR signaling promotes asymmetric cell division to direct CAR-T cell fate and antitumor potency. PubMed 42603278
- Nat Biomed Eng, 2026 (senior author): Bispecific killer cell engager-secreting CAR-T cells redirect natural killer specificity to enhance antitumour responses. PubMed 40659834
- Int J Cancer, 2025 (senior author): Prognostic impact of extramedullary disease in acute myeloid leukemia: A meta-analysis. PubMed 40558061
- Mil Med Res, 2025 (senior author): Clonal hematopoiesis of indeterminate potential: a multisystem hub bridging hematopoietic dysfunction with non-hematopoietic diseases. PubMed 41088446
- JCI Insight, 2025 (senior author): Enhancing the potency of CAR-T cells against solid tumors through transcription factor engineering. PubMed 40693464
- J Zhejiang Univ Sci B, 2025 (senior author): A case of cardiac arrest and spontaneous renal hemorrhage in a male patient with persistent eosinophilia: highlighting the importance of early diagnosis of eosinophilic granulomatosis with polyangiitis. PubMed 40722247
- Ann Hematol, 2025 (senior author): Selective efficacy of venetoclax in unfit patients with acute myeloid leukemia with myelodysplasia-related gene mutations under low-intensity therapy. PubMed 40399531
- Blood Rev, 2025 (senior author): BTK inhibitors resistance in B cell malignancies: Mechanisms and potential therapeutic strategies. PubMed 40000280
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that most papers list this doctor's hospital and department.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion